D Scott Coward reports a stock award at Humacyte
By AlphaYouPublished Form 4
COWARD D SCOTT
Reporting filer
D Scott Coward reports a stock award, not an open-market purchase or sale, in Humacyte, Inc.. Form 4 filed Oct 7, 2026 lists 1 entry.
- Disclosed
- Oct 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) (derivative) | COWARD D SCOTT | 2026-10-06 | A | Grant or award | 125000 | 0 | 125,000 | 1 day | Filed terms
|
Stock Options (right to buy) (derivative)
- Owner
- COWARD D SCOTT
- Date
- 2026-10-06
- Code
- A
- Action
- Grant or award
- Quantity
- 125000
- Price
- 0
- Following holdings
- 125,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Options (right to buy)
- conversion Or Exercise Price: 0.478
- transaction Date: 2026-10-06
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 125000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-06
- underlying Security Title: Common Stock
- underlying Security Shares: 125000
- shares Owned Following Transaction: 125000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- COWARD D SCOTT: Director.
- F1: The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030.
Original sources
Prepared automatically from public filing data. Report a correction.